|
Tue, 11/11/2025 - 13:17 |
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies |
VABIO |
|
Tue, 06/11/2024 - 21:52 |
Study reveals unexpected mechanism of drug resistance in kidney cancer |
UTSouthwestern |
|
Fri, 09/16/2022 - 01:41 |
MicroPort Announces Important Follow-up Results at ESC Congress 2022 |
MicroPort |
|
Wed, 06/01/2022 - 02:32 |
Paper Published in Cardiovascular Revascularization Medicine Shows Innovative Coronary Artery Implant is Capable of Moving with Vessel, Unlike Conventional Stents |
Elixir Medical |
|
Tue, 05/31/2022 - 20:22 |
DynamX Coronary Bioadaptor System |
Elixir Medical |
|
Tue, 10/12/2021 - 02:55 |
MicroPort Shared Latest Research Results at China Heart Congress (CHC) and 6th China Vascular Congress (CVC) |
MicroPort |
|
Fri, 05/21/2021 - 19:14 |
Temsirolimus Injection Now Available from Fresenius Kabi |
Fresenius Kabi |
|
Mon, 03/22/2021 - 09:14 |
Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib for the Prevention of Graft-Versus-Host Disease Published in Clinical Cancer Research |
CTI BioPharma |
|
Sun, 12/06/2020 - 05:37 |
CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Potential Benefit in Preventing Acute GVHD at the 62nd American Society of Hematology Meeting |
CTI BioPharma |
|
Tue, 10/13/2020 - 15:26 |
BryoLogyx Announces Completion of Worlds First GMP Synthesis of Bryostatin-1 |
AMRI |
|
Thu, 06/11/2020 - 03:10 |
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1 Synthesized by AMRI |
AMRI |
|
Wed, 05/13/2020 - 05:45 |
COVID-19 Prompts New Home Test for Kids with Organ Transplants |
Cincinnati Childrens |
|
Mon, 04/27/2020 - 14:38 |
Stanford chemists work on rare molecule aims to enhance cell therapy and deliver functional cure for HIV/AIDS |
StanfordUniv |
|
Mon, 04/20/2020 - 23:23 |
Clinical Trial for Everolimus Shows Decreased Tumor Volume for Patients With Benign Kidney Tumors |
Fox Chase Cance... |
|
Thu, 06/06/2019 - 00:22 |
Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible |
Novartis |
|
Fri, 05/31/2019 - 07:16 |
Envarsus XR to be Subject of Upcoming Presentations at 2019 American Transplant Congress |
Veloxis Pharmac... |
|
Mon, 05/06/2019 - 07:59 |
Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2019 |
Veloxis Pharmac... |
|
Tue, 02/26/2019 - 13:12 |
Reprogramming the wonder drug rapamycin allows creation of new small-molecule drugs |
HelsinkiUniv |
|
Mon, 02/25/2019 - 21:45 |
Reprogramming the wonder drug rapamycin allows creation of completely new small-molecule drugs |
HelsinkiUniv |
|
Wed, 10/10/2018 - 05:43 |
EISAI TO PRESENT ABSTRACTS ON ONCOLOGY PRODUCTS AND PIPELINE AT ESMO 2018 CONGRESS |
EISAI |
|
Mon, 07/30/2018 - 03:24 |
Transplant medication matters for controlling cancer risk |
QueenslandUniv |
|
Fri, 02/16/2018 - 07:23 |
Evaluating Quality of Life After Kidney Cancer Treatments |
Northwestern Un... |
|
Mon, 07/31/2017 - 23:02 |
Drug candidate discovered using iPS cells now in clinical trial (1 August 2017) |
KyotoUniversity |
|
Wed, 01/18/2017 - 22:38 |
Scientists from Northwell Healths Feinstein Institute Discuss Novel Drug Combination for Treating Cancer in Transplant Patients in New England Journal of Medicine |
Feinstein Institute |
|
Thu, 12/08/2016 - 05:46 |
BELLE-3 Trial Meets Primary Endpoint of Progression-free Survival in Breast Cancer Patients |
American Associ... |
